David Rolfe
Wedgewood Partners
Wedgewood Partners 13F holdings
David Rolfe's Portfolio
- Portfolio value:
- $578.93M≈
- # of securities:
- 40
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 15 Aug 2022
What was David Rolfe's 2022 Q2 portfolio?
Wedgewood Partners has disclosed a total of 40 security holdings in their (2022 Q2) SEC 13F filing(s) with portfolio value of $578,932,000.
Wedgewood Partners's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
David Rolfe's original 13F reports (2022 Q2) are the official SEC institutional disclosure documents covering all reported equity positions.
40 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Apple Inc
|
8.67%
|
367,275
|
$136.72
|
+142.03%($330.89)
|
$50,213,000
|
2013 Q2 or earlier
|
≈ 9.25+ years
|
Common Stock
|
-0.92% (-3.42K)
|
-0.07%
|
|
|
|
Visa Inc, CL-A
|
6.68%
|
196,545
|
$196.89
|
+81.80%($357.94)
|
$38,697,000
|
2013 Q2 or earlier
|
≈ 9.25+ years
|
Common Stock
|
-10.04% (-21.93K)
|
-0.61%
|
|
|
|
Microsoft Corp
|
6.26%
|
141,226
|
$256.82
|
+52.93%($392.76)
|
$36,270,000
|
2020 Q1
|
≈ 2.50 years
|
Common Stock
|
-0.60% (-853)
|
-0.03%
|
|
|
|
Alphabet Inc, CL-A
|
6.20%
|
329,240
|
$108.96
|
+217.63%($346.09)
|
$35,874,000
|
2014 Q2
|
≈ 8.25 years
|
Common Stock
|
-0.90% (-3K)
|
-0.05%
|
|
|
|
Meta Platforms Inc
|
6.06%
|
217,756
|
$161.24
|
+299.66%($644.43)
|
$35,112,000
|
2018 Q1
|
≈ 4.50 years
|
Common Stock
|
-0.60% (-1.31K)
|
-0.03%
|
|
|
|
Motorola Solutions Inc
|
6.06%
|
167,263
|
$209.59
|
+98.74%($416.54)
|
$35,057,000
|
2019 Q2
|
≈ 3.25 years
|
Common Stock
|
-0.48% (-809)
|
-0.02%
|
|
|
|
Tractor Supply Company
|
6.02%
|
179,920
|
$193.85
|
-84.16%($30.70)
|
$34,877,000
|
2016 Q4
|
≈ 5.75 years
|
Common Stock
|
-13.33% (-27.67K)
|
-0.76%
|
|
|
|
Edwards Lifesciences Corp
|
5.60%
|
340,689
|
$95.09
|
-9.52%($86.03)
|
$32,395,000
|
2017 Q1
|
≈ 5.50 years
|
Common Stock
|
-4.89% (-17.53K)
|
-0.24%
|
|
|
|
UnitedHealth Group Incorporated
|
5.54%
|
62,486
|
$513.62
|
-15.77%($432.61)
|
$32,094,000
|
2021 Q3
|
≈ 1.00 year
|
Common Stock
|
-1.15% (-730)
|
-0.05%
|
|
|
|
CDW Corp
|
5.05%
|
185,496
|
$157.56
|
-16.01%($132.33)
|
$29,226,000
|
2019 Q3
|
≈ 3.00 years
|
Common Stock
|
-1.84% (-3.47K)
|
-0.08%
|
|
Completely sold out
4 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Vanguard Growth Index Fund ETF Shares
|
-11,760
|
-0.08%
|
2022 Q1
|
≈ 0.25 years
|
|
|
|
Toronto Dominion Bank
|
-2,750
|
-0.03%
|
2022 Q1
|
≈ 0.25 years
|
|
|
|
Tapestry Inc
|
-5,750
|
-0.03%
|
2022 Q1
|
≈ 0.25 years
|
|
|
|
Exxon Mobil Corp
|
-2,500
|
-0.03%
|
2022 Q1
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.